imatinib mesylate has been researched along with Sarcoma, Endometrial Stromal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agorastos, T; Bontis, J; Theodoridis, TD; Venizelos, ID; Zafrakas, M; Zepiridis, L | 1 |
BalaƱa, C; Gomez, C; Salvatierra, A; Sastre, JM; Tarrats, A | 1 |
1 review(s) available for imatinib mesylate and Sarcoma, Endometrial Stromal
Article | Year |
---|---|
KIT protein expression in uterine sarcomas: an immunohistochemical study and review of the literature.
Topics: Benzamides; Endometrial Neoplasms; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Leiomyosarcoma; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma, Endometrial Stromal | 2008 |
1 other study(ies) available for imatinib mesylate and Sarcoma, Endometrial Stromal
Article | Year |
---|---|
A case of c-kit positive high-grade stromal endometrial sarcoma responding to Imatinib Mesylate.
Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma, Endometrial Stromal; Vaginal Neoplasms | 2006 |